We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

REE:NASDAQREE Automotive Ltd. Analysis

Data as of 2026-05-19 - not real-time

$0.42

Latest Price

8/10Risk

Risk Level: High

Executive Summary

REE Automotive is trading well below its short‑ and medium‑term moving averages, with the price sitting under the 20‑day, 50‑day and 200‑day SMA bands, underscoring a persistent bearish bias. The RSI is hovering in the low‑30s, suggesting the stock is technically oversold yet momentum remains weak, as confirmed by a bearish MACD histogram and a MACD line that sits beneath its signal line. Volatility is exceptionally high, exceeding 70% over the past 30 days, and the beta of roughly 1.3 signals amplified moves relative to the broader market, amplifying downside risk. Fundamentally, the company reports negative operating margins, substantial operating cash‑flow deficits and a debt‑to‑equity ratio above 280%, indicating a strained balance sheet with limited financial flexibility. No dividend is paid and the price‑to‑book ratio is well under one, reflecting a market perception of deep discount relative to book value, but the price‑to‑sales multiple remains elevated, hinting at overvaluation on a sales basis. The recent filing of a supplemental proxy statement for a special shareholders’ meeting adds a layer of governance uncertainty that could affect investor confidence. Coupled with a “Extreme Greed” sentiment reading, the market appears eager despite the company’s precarious fundamentals, creating a classic high‑risk, low‑reward scenario.
Given the confluence of bearish technical signals, deteriorating financial health, high volatility, and elevated sector and liquidity risks, the outlook remains decidedly negative. Investors should weigh the substantial downside potential against any speculative upside from a potential turnaround, which appears unlikely without significant capital infusion or strategic partnership. Caution is advised, and any exposure should be limited to a small, speculative portion of a diversified portfolio.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 9/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and low RSI
  • Elevated volatility and beta

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Continued negative cash flow and high debt load
  • Uncertain governance after special shareholders’ meeting
  • Lack of dividend and weak earnings outlook

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside if the company secures strategic partnerships or financing
  • Low price‑to‑book may offer marginal value if turnaround occurs
  • Persistent sector cyclicality and competitive pressure

Key Metrics & Analysis

Financial Health

Revenue Growth4537.50%
P/E Ratio-0.2
ROE-373.57%
ROA-78.96%
Debt/Equity283.87
P/B Ratio0.3
Op. Cash Flow$-68710000
Free Cash Flow$-63804248

Technical Analysis

TrendBearish
RSI33.4
Support$0.40
Resistance$0.61
MA 20$0.49
MA 50$0.56
MA 200$0.72
MACDBearish
VolumeIncreasing
Fear & Greed Index89.2

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta1.32
Volatility71.87%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.